Click here for slides on this topic


Angiotensin-receptor blocker (ARB)

Angiotensin receptor blockers are medications that modulate the renin-angiotensin-aldosterone system. These drugs block the action of angiotensin II, permitting the blood vessels to relax and dilate, which lowers blood pressure. ARBs are primarily used for the treatment of hypertension when treatment with an ACE inhibitor cannot be tolerated by the patient.
The following content matched the glossary term: Angiotensin-receptor blocker (ARB)

AACE 2015 guidelines Cardiovascular Disease Management

Top

Summary of recommendations for managing cardiovascular disease (CVD), including dyslipidemia and hypertension, from the 2015 AACE diabetes guidelines 

Endocrine Society Guideline on Diabetes and Pregnancy - Glycemic Targets & Glucose Management

Top

Diabetes Management Guidelines Endocrine Society Guideline on Diabetes and Pregnancy   Source Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013 98(11) 4227 4249. Available here.Refer to

ADA 2016 Cardiovascular Disease (CVD) and Diabetes

Top

Recommendations for CVD management, including lipids and BP, in patients with type 2 diabetes from the 2016 ADA diabetes guidelines

Treating the Patient With Newly Diagnosed Type 2 Diabetes - Pretest

Top

Patient case: 56-Year-Old Woman with Newly Diagnosed Type 2 Diabetes, Overweight, and Mild Hypertension

Presented by Anne Peters, MD

Treating the Patient With Newly Diagnosed Type 2 Diabetes - References

Top

Patient case: 56-Year-Old Woman with Newly Diagnosed Type 2 Diabetes, Overweight, and Mild Hypertension

Presented by Anne Peters, MD

Treating the Patient With Newly Diagnosed Type 2 Diabetes - Key Take-Home Messages

Top

Patient case: 56-Year-Old Woman with Newly Diagnosed Type 2 Diabetes, Overweight, and Mild Hypertension

Presented by Anne Peters, MD

Treating the Patient With Newly Diagnosed Type 2 Diabetes - Treatment Recommendations

Top

Patient case: 56-Year-Old Woman with Newly Diagnosed Type 2 Diabetes, Overweight, and Mild Hypertension

Presented by Anne Peters, MD

Treating the Patient With Newly Diagnosed Type 2 Diabetes - Case Discussion - Pharmacologic Therapy

Top

Patient case: 56-Year-Old Woman with Newly Diagnosed Type 2 Diabetes, Overweight, and Mild Hypertension

Presented by Anne Peters, MD

Treating the Patient With Newly Diagnosed Type 2 Diabetes - Case Discussion - Lifestyle Changes

Top

Patient case: 56-Year-Old Woman with Newly Diagnosed Type 2 Diabetes, Overweight, and Mild Hypertension   

Presented by Anne Peters, MD 

Treating the Patient With Newly Diagnosed Type 2 Diabetes - Case Discussion - A1C Target

Top

Patient case: 56-Year-Old Woman with Newly Diagnosed Type 2 Diabetes, Overweight, and Mild Hypertension   

Presented by Anne Peters, MD 

 

1 2 3 Next 

Slide Library Results

Search Results for: Angiotensin-receptor blocker (ARB) Slides Found: 5
New Onset Diabetes in Clinical Trials of Antihypertensive Drugs: A Meta-analysis
ALTITUDE: No Reduction in CV, Renal Events with Aliskiren
ALTITUDE: Increased Hyperkalemia, Renal Impairment with Aliskiren
JNC 8 Guidelines First-Line Antihypertensive Therapy PPT | NDEI
JNC 8 Guidelines Treatment Hypertension CKD PPT | NDEI